Authors:
KIROV I
GOLDMAN S
BLAZAR B
VANDEVEN C
DAVENPORT G
REAMAN G
LAVER J
KREISSMAN S
BERG S
KAYE J
PATTERSON F
HUTABARAT R
DYKSTRA K
CAIRO MS
Citation: I. Kirov et al., RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(R)) IS TOLERATED AT DOUBLE THE ADULT DOSE AND ENHANCES HEMATOPOIETIC RECOVERY FOLLOWING IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE) CHEMOTHERAPY IN CHILDREN - CORRELATION WITH RAPID CLEARANCE, LACK OF INDUCTION OF INFLAMMATORY CYTOKINES AND MOBILIZATION OF EARLY PROGENITOR CELLS, Blood, 90(10), 1997, pp. 2584-2584
Authors:
HUSSEIN A
VREDENBURGH J
ELKORDY M
RUBIN P
FISHER D
CANALES R
PETROS W
GILBERT C
PERET N
DYKSTRA K
LOEWY J
KAYE JA
PETERS WP
Citation: A. Hussein et al., RANDOMIZED, PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(TM) RHIL-11 GROWTH-FACTOR) IN PATIENTS WITH BREAST-CANCERFOLLOWING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL (AHPC) SUPPORT, Experimental hematology, 24(9), 1996, pp. 634-634
Authors:
HUSSEIN A
FISHER D
VREDENBURGH J
RUBIN P
ELKORKY M
PETER W
PERET N
DYKSTRA K
KAYE JA
Citation: A. Hussein et al., PHASE-2 TRIAL OF NEUMEGA(R) RHIL-11 IN PATIENTS WITH BREAST-CANCER AFTER HIGH-DOSE CHEMOTHERAPY WITH BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL SUPPORT, Blood, 88(10), 1996, pp. 1189-1189